WANBURY
|
The Current P/S Ratio of WANBURY is 1.47.
| Share Price | ₹265.9 | Jun 09,2026 |
| Market Cap | ₹928.0 Cr | |
| Sales-TTM | ₹629.8 Cr | TTM-Consolidated Results |
| Price/Sales | 1.47x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of WANBURY
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹928.0 Cr] as on Jun 09,2026
(/) Sales [ ₹629.8 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.47x ]
Thus, for WANBURY , the investors are currently willing to pay '1.47 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WANBURY !
The chart below summarizes the trend in P/S Ratio of WANBURY over the last five years.
Historical PS (Price/Sales) ratio chart of WANBURY
PS Ratio Performance Analysis for WANBURY
- WANBURY 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.68x.
- WANBURY 's operated at median p/e ratio of 0.54x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WANBURY 's p/e ratio peaked in Mar2025 at 1.28x.
- WANBURY 's p/e ratio hit its five-year low in Mar2023 of 0.24x.
How does WANBURY 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| WANBURY | 629.8 | 1.47 | 928.0 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.30 | 426,938.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.98 | 179,361.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 10.83 | 151,385.0 |
| CIPLA LTD | 28,162.6 | 3.95 | 111,220.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.14 | 105,899.0 |
| MANKIND PHARMA LTD | 14,277.6 | 6.92 | 98,745.3 |
| LUPIN LTD | 27,958.0 | 3.70 | 103,490.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.10 | 111,264.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.47 | 83,208.3 |
| LAURUS LABS LTD | 6,812.9 | 11.30 | 76,955.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WANBURY 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.47x |
| Max industry PS | 16.98x |
| Median industry PS | 4.10x |
| Average industry PS | 6.56x |
You may also like the below Video Courses